Private Client Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
881
+50
+6% +$51.1K 0.28% 74
2026
Q1
$764K Buy
831
+9
+1% +$9.12K 0.23% 82
2025
Q4
$883K Sell
822
-18
-2% -$17.2K 0.28% 70
2025
Q3
$641K Sell
840
-407
-33% -$303K 0.21% 85
2025
Q2
$972K Buy
1,247
+85
+7% +$66.1K 0.38% 68
2025
Q1
$959K Sell
1,162
-10
-0.9% -$8.32K 0.47% 53
2024
Q4
$905K Buy
1,172
+96
+9% +$79.5K 0.49% 57
2024
Q3
$953K Buy
1,076
+95
+10% +$85.4K 0.51% 55
2024
Q2
$888K Buy
981
+22
+2% +$17.6K 0.56% 48
2024
Q1
$746K Buy
959
+27
+3% +$19.2K 0.5% 56
2023
Q4
$543K Buy
+932
New +$544K 0.45% 73

Other funds holding LLY

Private Client Services's LLY Position: Q2 2026 in Review

Private Client Services increased its Eli Lilly (LLY) stake by 6% in Q2 2026, buying an estimated $51.1K and bringing the position to 881 shares worth $1.06M. The position accounts for 0.28% of the portfolio, ranked #74.

Private Client Services first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,742 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Private Client Services held 881 shares of Eli Lilly worth $1.06M as of Q2 2026.
  • Private Client Services bought 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.28% of Private Client Services's portfolio in Q2 2026, its #74 holding.
  • Private Client Services first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,742 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Private Client Services's 13F filing for Q2 2026, filed 6 Jul 2026.